Share Market Highlights: Sensex jumps 1.4%, Nifty gains 1.32% as foreign buying lifts markets
Sensex, Nifty updates on 24 March 2025. The benchmark BSE Sensex jumped 1.4% to 77,984.38, while the NSE Nifty gained 1.32% ...
FDA approves first new UTI drug in decades
The Food and Drug Administration (FDA) has approved a new drug for treating urinary tract infections, the first such drug ...
US FDA approves Sanofi's bleeding disorder therapy
The U.S. Food and Drug Administration approved French drugmaker Sanofi's hemophilia therapy, introducing a new type of ...
BioPharma Dive1d
FDA approves first-of-its-kind RNA drug for hemophilia
The Sanofi drug, known as fitusiran and now Qfitlia, was approved on Friday for a broad group of people with the rare ...
US FDA approves first treatment for rare genetic disorder Prader-Willi syndrome
The U.S. Food and Drug Administration on Wednesday approved Soleno Therapeutics' drug to treat a rare genetic disorder, ...
Here’s what to know about Blujepa, the new FDA-approved UTI treatment heading to market this year
GSK's pill, the first oral antibiotic for urinary tract infections in almost 30 years, comes as bacteria are increasingly ...
Healio3d
FDA recap: First new treatment for stroke in 3 decades, generic rivaroxaban and more
Recent FDA actions include approval of the first new treatment for acute stroke in 30 years. FDA also cleared a pulse detection feature on a smartwatch and an AI-assisted image analysis app.
Global News4d
FDA approves new antibiotic to treat UTIs in females
The FDA in October last year approved another oral antibiotic, Orlynvah, developed by Irish biotech firm Iterum Therapeutics, for the treatment of certain types of bacterial UTIs in adult women.
Monthly Prescribing Reference25d
FDA Approves First Generics of Anticoagulant Xarelto
The approval is only for the 2.5mg tablet. The Food and Drug Administration (FDA) has approved the first generics of Xarelto ® (rivaroxaban) 2.5mg. Xarelto 2.5mg is used, in combination with ...
Healio26d
FDA approves TNKase for acute ischemic stroke in adults
TNKase is the first stroke treatment approved by the FDA in almost 30 years, the manufacturer said. It is approved for administration as a single 5-second IV bolus. The FDA has approved TNKase ...
Top Vaccine Official Resigns From FDA, Criticizes RFK Jr. for Promoting Misinformation, Lies
FDA's vaccine chief steps down, warning of 'unprecedented assault on scientific truth' in public health sector.